The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys

BACKGROUND: Activation of the peroxisome proliferator-activated receptor gamma (PPAR-γ) has been proposed as a possible neuroprotective strategy to slow down the progression of early Parkinson's disease (PD). Here we report preclinical data on the use of the PPAR-γ agonist pioglitazone (Actos(®...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Swanson, Christine R, Joers, Valerie, Bondarenko, Viktoriya, Brunner, Kevin, Simmons, Heather A, Ziegler, Toni E, Kemnitz, Joseph W, Johnson, Jeffrey A, Emborg, Marina E
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2011
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3166925/
https://ncbi.nlm.nih.gov/pubmed/21819568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-2094-8-91
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares